These 3 non-tobacco risks are rewriting lung cancer epidemiology

By MDLinx staffPublished November 12, 2025


Industry Buzz

It’s officially November 1st, marking the start of Lung Cancer Awareness Month, and I couldn’t miss the chance to spotlight lung cancer in people who’ve never smoked.

—Eric K. Singhi, MD, @lungoncdoc

When Eric K. Singhi, MD, took to TikTok to mark Lung Cancer Awareness Month, his opening line to patients was blunt: "Up to 1 in 5 lung cancer cases occur in individuals with no smoking history."

It’s a data-backed reminder that lung cancer is not confined to tobacco exposure. Clinicians are all too aware of this, of course, but your patients likely aren't. Dr. Singhi's message is that it’s high time to recalibrate the patient reflex that “no smoking equals low risk.”

Below, three key non-tobacco risk factors worth reminding your patients about—each with diagnostic, preventive, and counseling implications.

Radon gas exposure

One of the more silent, invisible risk factors is radon gas that infiltrates the home or workplace.

What the evidence says

  • A recent meta‐analysis of residential radon exposure found that among never‐smokers, the adjusted excess relative risk (aERR) per 100 Bq/m³ was 0.15 (95 % CI 0.06–0.25). []

  • The Environmental Protection Agency (EPA) in the US estimates that radon is the number one cause of lung cancer among non‑smokers, and the second leading cause overall after smoking. []

  • A summary review noted that exposure to radon, secondhand smoke, and outdoor/indoor air pollution are among the leading environmental risks in non‑smokers. []

Clinical implications

  • For patients with lung cancer who have never smoked (or minimal exposure), assessing residential/workplace radon exposure should be part of the history.

  • In regions (like parts of Pennsylvania) where radon levels are known to be elevated, non‐smoker patients with suspicious imaging (nodules or early lesions) might warrant a lower threshold for work‑up.

  • While screening guidelines do not include never‐smokers (yet) based on radon exposure only, some advocate for targeted screening in “high environmental exposure” settings.

  • Because radon exposure is modifiable (via home testing and mitigation), this is a genuine prevention opportunity.

Related: You need to take a closer look at this targeted therapy for lung cancer

Outdoor air pollution/fine particulates

Another “invisible” risk factor is ambient air quality—especially fine particulate matter (PM₂.₅) and diesel/industrial emissions. Dr. Singhi flags “outdoor air pollution (PM2.5)” as part of the risk portfolio for lung cancer in never‑smokers.

Research update

  • A 2023 review in the Journal of Thoracic Oncology reported that air pollution (including PM₂.₅) is a carcinogen for lung cancer, and that the dose–response holds, especially in non‐smokers. []

  • An environmental/occupational exposure review noted that industrialization, outdoor/indoor pollutants, and so‑called “solid fuel use” for cooking/heating remain strong risk factors for lung cancer among non‐smokers globally. []

Clinical take‑home

  • For never‐smoker patients with lung‑cancer diagnoses (especially adenocarcinoma histology), it is reasonable to ask about long‑term residence near busy roads, industrial sites, or regions with poor air quality.

  • For general primary prevention counseling: While we can’t eliminate ambient pollution entirely, advocating for indoor air hygiene (ventilation, avoiding indoor biomass/coal burning, filtering) remains relevant.

  • In research settings, refining risk models for never‐smokers may need incorporation of ambient/indoor air exposure metrics.

Occupational exposures (asbestos, silica, etc.)

Dr. Singhi lists “occupational exposures (asbestos, silica)” as another cornerstone non‑smoking lung‑cancer risk.

Evidence base

  • A 2019 review of environmental/occupational determinants noted that while smoking still accounts for the majority of lung cancer risk, a significant and preventable fraction in non‐smokers is attributable to occupational carcinogens (arsenic, asbestos, silica, diesel exhaust). []

  • Another study focusing on radical occupational exposures highlighted that for never‐smokers the absence of the “classic” tobacco signature means we have to pay closer attention to non‐tobacco carcinogens and their synergistic effects. []

For your practice

  • In the work‑up of a never‐smoker with lung cancer (or someone with suspicious pulmonary nodules and exposure history), ask about lifetime occupational history: shipbuilding, mining, construction, insulation work, silica dust, heavy metal exposure.

  • This may influence both the suspicion for malignancy (i.e., lower threshold for imaging/follow‑up) and possibly influence regulatory/occupational‑medicine follow‑up.

  • When counseling patients at risk (even non‑smokers), emphasizing use of protective equipment, dust control, workplace surveillance remains worthwhile.

Related: New insights into lung cancer screening guidelines

SHARE THIS ARTICLE

ADVERTISEMENT